The Hear Clear Study

Part of paid clinical trials in Durham, North Carolina.

Sponsor
Duke University
Study ID
NCT07824115
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Functional Hearing Difficulties

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Signal-to-Noise Ratio Enhancement (SNR+) — OTHER
    Participants will be randomly assigned to either the open dome or closed dome group (Factor 1). Participants will then obtain their first treatment arm with a random assignment of either an SNR neutral (SNR-) or SNR enhanced (SNR+) hearing aid fitting (Factor 2). They will return to the lab for testing prior to crossing over to the second arm (the other SNR configuration: SNR- or SNR+). The SNR+ setting contains features to improve the signal-to-noise ratio of the sound to optimize speech over noise through the hearing aids.
  • Signal-to-Noise Ratio Neutral (SNR-) — OTHER
    Participants will be randomly assigned to either the open dome or closed dome group (Factor 1). Participants will then obtain their first treatment arm with a random assignment of either an SNR neutral (SNR-) or SNR enhanced (SNR+) hearing aid fitting (Factor 2). They will return to the lab for unaided baseline testing prior to crossing over to the second arm (the other SNR configuration: SNR- or SNR+). The SNR- setting contains focuses on improving audibility of sounds through the hearing aids.

Study Details

The purpose of this study is to determine if hearing aid use helps adults with "normal" hearing on clinical hearing tests (i.e., pure-tone audiogram), but who report hearing trouble in everyday life. Another purpose is to understand what factors and hearing aid features provide the most help for these people.

Key Dates

First listed
Sep 17, 2026
Start date
Jan 31, 2027
Status verified
Sep 2026
Primary completion
May 31, 2030
Completion
May 31, 2030

Study Design

Enrollment
125 participants (estimated)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT

Arms

  • Experimental: Open-dome receiver-in-canal hearing aids
    Air-conduction receiver-in-canal (RIC) hearing aids with open domes, which have holes or vents that let natural sound and air pass into the ear canal.
  • Experimental: Closed-dome receiver-in-canal hearing aids
    Air-conduction receiver-in-canal (RIC) hearing aids with closed domes, which have solid rubber with tiny or no vents to seal the ear.

Primary Outcome Measure

Revised Hearing Handicap Inventory (RHHI) [ Time Frame: Baseline (unaided), 4 weeks (aided with intervention 1), 4 weeks (after wash-out period, and unaided), and 4 weeks (aided with intervention 2) ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Duke University Medical CenterDurhamNorth Carolina27710
Jenny L Norris, MA
919-681-2137
Sherri L Smith, Au.D., Ph.D.
919-613-1110
Sherri L Smith, Au.D., Ph.D. (PRINCIPAL_INVESTIGATOR)
The Ohio State UniversityColumbusOhio43210
Christina M Roup, Ph.D.
614-247-8614
Christina M Roup, Ph.D. (PRINCIPAL_INVESTIGATOR)

Find similar trials in Durham, NC